|
1
|
Jacobs JJ, Roebuck KA, Archibeck M, Hallab
NJ and Glant TT: Osteolysis: basic science. Clin Orthop Rel Res.
393:71–77. 2001. View Article : Google Scholar
|
|
2
|
Ingham E and Fisher J: The role of
macrophages in osteolysis of total joint replacement. Biomaterials.
26:1271–1286. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Haynes DR, Crotti TN, Potter AE, et al:
The osteoclastogenic molecules RANKL and RANK are associated with
periprosthetic osteolysis. J Bone Joint Surg Br. 83:902–911. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kobayashi A, Freeman MA, Bonfield W, et
al: Number of polyethylene particles and osteolysis in total joint
replacements. A quantitative study using a tissue-digestion method.
J Bone Joint Surg Br. 79:844–848. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sabokbar A, Fujikawa Y, Neale S, Murray DW
and Athanasou NA: Human arthroplasty derived macrophages
differentiate into osteoclastic bone resorbing cells. Ann Rheum
Dis. 56:414–420. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sabokbar A, Pandey R and Athanasou NA: The
effect of particle size and electrical charge on
macrophage-osteoclast differentiation and bone resorption. J Mater
Sci Mater Med. 14:731–738. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
González O, Smith RL and Goodman SB:
Effect of size, concentration, surface area, and volume of
polymethylmethacrylate particles on human macrophages in vitro. J
Biomed Mater Res. 30:463–473. 1996.PubMed/NCBI
|
|
8
|
O’Keefe RJ, Rosier RN, Teot LA, Stewart JM
and Hicks DG: Cytokine and matrix metalloproteinase expression in
pigmented villonodular synovitis may mediate bone and cartilage
destruction. Iowa Orthop J. 18:26–34. 1998.PubMed/NCBI
|
|
9
|
Xu JW, Konttinen YT, Lassus J, Natah S,
Ceponis A and Solovieva S: Tumor necrosis factor-alpha (TNF-alpha)
in loosening of total hip replacement (THR). Clin Exp Rheumatol.
14:643–648. 1996.PubMed/NCBI
|
|
10
|
Ross FP: RANKing the importance of measles
virus in Paget’s disease. J Clin Invest. 105:555–558. 2000.
|
|
11
|
Kobayashi K, Takahashi N, Jimi E, et al:
Tumor necrosis factor-α stimulates osteoclast differentiation by a
mechanism independent of the ODF/RANKLRANK interaction. J Exp Med.
191:275–286. 2000.
|
|
12
|
Azuma Y, Kaji K, Katogi R, Takeshita S and
Kudo A: TNF-α induces differentiation of and bone resorption by
osteoclasts. J Biol Chem. 275:4858–4864. 2000.
|
|
13
|
Qin CQ, Ding Y, Huang DS, Xu J, Ma RF and
Huang JB: Down-regulation of TNF-alpha by small interfering RNA
inhibits particle-induced Inflammation in vitro. Artif Organs.
35:706–714. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Howard KA, Paludan SR, Behlke MA,
Besenbacher F, Deleuran B and Kjems J: Chitosan/siRNA
nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages
for anti-inflammatory treatment in a murine arthritis model. Mol
Ther. 17:162–168. 2009. View Article : Google Scholar
|
|
15
|
Suzuki A, Thies RS, Yamaji N, Song JJ,
Wozney JM and Murakami K: A truncated bone morphogenetic protein
receptor affects dorsal-ventral patterning in the early Xenopus
embryo. Proc Natl Acad Sci USA. 91:10255–10259. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yamaji N, Celeste AJ, Thies RS, et al: A
mammalian serine/threonine kinase receptor specifically binds BMP-2
and BMP-4. Biochem Biophys Res Commun. 205:1944–1951. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Abe E, Yamamoto M, Taguchi Y, et al:
Essential requirement of BMPs-2/4 for both osteoblast and
osteoclast formation in murine bone marrow cultures from adult
mice: antagonism by noggin. J Bone Miner Res. 15:663–673. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wutzl A, Brozek W, Lernbass I, et al: Bone
morphogenetic proteins 5 and 6 stimulate osteoclast generation. J
Biomed Mater Res A. 77:75–83. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jensen ED, Pham L, Billington CJ Jr, et
al: Bone morphogenic protein 2 directly enhances differentiation of
murine osteoclast precursors. J Cell Biochem. 109:672–682.
2010.PubMed/NCBI
|
|
20
|
Giannoudis PV, Kanakaris NK and Einhorn
TA: Interaction of bone morphogenetic proteins with cells of the
osteoclast lineage: review of the existing evidence. Osteoporos
Int. 18:1565–1581. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Falany ML, Thames AM III, McDonald JM, et
al: Osteoclasts secrete the chemotactic cytokine mim-1. Biochem
Biophys Res Commun. 281:180–185. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Roodman GD: Regulation of osteoclast
differentiation. Ann NY Acad Sci. 1068:100–109. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Abbas S, Clohisy JC and Abu Amer Y:
Mitogen-activated protein (MAP) kinases mediate PMMA-induction of
osteoclasts. J Orthop Res. 21:1041–1048. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Grigoriadis AE, Wang ZQ, Cecchini MG, et
al: c-Fos: a key regulator of osteoclast-macrophage lineage
determination and bone remodeling. Science. 266:443–448. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zheng Y, Wang L, Zhang X, et al: BMP2/7
heterodimer can modulate all cellular events of the in vitro
RANKL-mediated osteoclastogenesis, respectively, in different dose
patterns. Tissue Eng Part A. 18:621–630. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Anderson RD, Haskell RE and Xia H: A
simple method for the rapid generation of recombinant adenovirus
vectors. Gene Ther. 7:1034–1038. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Palmer GD, Gouze E, Gouze JN, Betz OB,
Evans CH and Ghivizzani SC: Gene transfer to articular chondrocytes
with recombinant adenovirus. Methods Mol Biol. 215:235–246.
2003.PubMed/NCBI
|
|
28
|
Takayanagi H, Kim S, Koga T, et al:
Induction and activation of the transcription factor NFATc1 (NFAT2)
integrate RANKL signaling in terminal differentiation of
osteoclasts. Dev Cell. 3:889–901. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Novack DV and Teitelbaum SL: The
osteoclast: friend or foe? Annu Rev Pathol. 3:457–484. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yagi M, Miyamoto T, Sawatani Y, et al:
DC-STAMP is essential for cell-cell fusion in osteoclasts and
foreign body giant cells. J Exp Med. 202:345–351. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hsu H, Lacey DL, Dunstan CR, et al: Tumor
necrosis factor receptor family member RANK mediates osteoclast
differentiation and activation induced by osteoprotegerin ligand.
Proc Natl Acad Sci USA. 96:3540–3545. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Arai A, Mizoguchi T, Harada S, et al: Fos
plays an essential role in the upregulation of RANK expression in
osteoclast precursors within the bone microenvironment. J Cell Sci.
125:2910–2917. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Abu-Amer Y, Darwech I and Clohisy JC:
Aseptic loosening of total joint replacements: mechanisms
underlying osteolysis and potential therapies. Arthritis Res Ther.
9(Suppl 1): S62007. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shen Z, Crotti TN, McHugh KP, et al: The
role played by cell-substrate interactions in the pathogenesis of
osteoclast-mediated peri-implant osteolysis. Arthritis Res Ther.
8:R702006. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cao X and Chen D: The BMP signaling and in
vivo bone formation. Gene. 357:1–8. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bessa PC, Casal M and Reis RL: Bone
morphogenetic proteins in tissue engineering: the road from
laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen
Med. 2:81–96. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gautschi OP, Frey SP and Zellweger R: Bone
morphogenetic proteins in clinical applications. ANZ J Surg.
77:626–631. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kirker-Head CA, Boudrieau RJ and Kraus KH:
Use of bone morphogenetic proteins for augmentation of bone
regeneration. J Am Vet Med Assoc. 231:1039–1055. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li G, Li Q, Lin LJ, Duan X and Zhang XQ:
Slow-release recombinant human bone morphogenetic protein-2
suppresses chromium wear particle-induced osteolysis in rats. Nan
Fang Yi Ke Da Xue Xue Bao. 32:391–395. 2012.(In Chinese).
|
|
40
|
Helgeson MD, Lehman RA Jr, Patzkowski JC,
Dmitriev AE, Rosner MK and Mack AW: Adjacent vertebral body
osteolysis with bone morphogenetic protein use in transforaminal
lumbar interbody fusion. Spine J. 11:507–510. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Southwood LL, Frisbie DD, Kawcak CE,
Ghivizzani SC, Evans CH and McIlwraith CW: Evaluation of Ad-BMP-2
for enhancing fracture healing in an infected defect fracture
rabbit model. J Orthop Res. 22:66–72. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Beraudi A, Stea S, Cremonini S, Visentin M
and Toni A: Assessment of five interleukins in human synovial fluid
as possible markers for aseptic loosening of hip arthroplasty.
Artif Organs. 33:538–543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lam J, Takeshita S, Barker JE, Kanagawa O,
Ross FP and Teitelbaum SL: TNF-alpha induces osteoclastogenesis by
direct stimulation of macrophages exposed to permissive levels of
RANK ligand. J Clin Invest. 106:1481–1488. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Huang H, Chang EJ, Ryu J, Lee ZH, Lee Y
and Kim HH: Induction of c-Fos and NFATc1 during RANKL-stimulated
osteoclast differentiation is mediated by the p38 signaling
pathway. Biochem Biophys Res Commun. 351:99–105. 2006. View Article : Google Scholar : PubMed/NCBI
|
